Ho, S.-Y.; Liu, P.-H.; Hsu, C.-Y.; Huang, Y.-H.; Liao, J.-I.; Su, C.-W.; Hou, M.-C.; Huo, T.-I.
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers 2022, 14, 4207.
https://doi.org/10.3390/cancers14174207
AMA Style
Ho S-Y, Liu P-H, Hsu C-Y, Huang Y-H, Liao J-I, Su C-W, Hou M-C, Huo T-I.
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers. 2022; 14(17):4207.
https://doi.org/10.3390/cancers14174207
Chicago/Turabian Style
Ho, Shu-Yein, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, and Teh-Ia Huo.
2022. "Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score" Cancers 14, no. 17: 4207.
https://doi.org/10.3390/cancers14174207
APA Style
Ho, S.-Y., Liu, P.-H., Hsu, C.-Y., Huang, Y.-H., Liao, J.-I., Su, C.-W., Hou, M.-C., & Huo, T.-I.
(2022). Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers, 14(17), 4207.
https://doi.org/10.3390/cancers14174207
